Abstracts tagged "classification criteria and systemic lupus erythematosus (SLE)"

Abstract Number: 1686 • 2018 ACR/ARHP Annual Meeting
Rule-Based Algorithm Using Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria to Identify Patients with Systemic Lupus Erythematosus (SLE) from Electronic Health Record (EHR) Data
Anika S. Ghosh¹, Theresa L. Walunas², Kathryn L. Jackson¹, Ahn H. Chun³, Daniel L. Erickson³, Karen Mancera-Cuevas⁴, Abel N. Kho³ and Rosalind Ramsey-Goldman⁵, ¹Center for Health Information Partnerships, Northwestern University, Chicago, IL, ²Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University, Chicago, IL, ³Northwestern University, Chicago, IL, ⁴Rheumatology, Northwestern University, Chicago, IL, ⁵FSM, Northwestern University, Chicago, IL
Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect many parts of the body including skin, lungs, brain, heart, kidneys, joints, and…
Abstract Number: 1712 • 2018 ACR/ARHP Annual Meeting
Validation of Proposed EULAR/Acr SLE Classification Criteria Versus SLICC SLE Classification Criteria
Michelle Petri¹, Daniel Goldman¹ and Laurence S Magder², ¹Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, ²Epidemiology and Public health, University of Maryland School of Medicine, Baltimore, MD
Background/Purpose: The SLICC 2012 SLE classification criteria and the revised ACR-11 criteria count each SLE manifestation equally. We validated the recently proposed EULAR/ACR classification rule…
Abstract Number: 2152 • 2018 ACR/ARHP Annual Meeting
A Comparison of the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics Classification (SLICC) Criteria to Detect Patients with Systemic Lupus Erythematosus (SLE) in Electronic Health Record (EHR) Data
Theresa L. Walunas¹, Anika S. Ghosh², Kathryn L. Jackson³, Ahn H. Chun², Daniel L. Erickson², Karen Mancera-Cuevas⁴, Abel N. Kho² and Rosalind Ramsey-Goldman⁵, ¹Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University, Chicago, IL, ²Northwestern University, Chicago, IL, ³Center for Health Information Partnerships, Northwestern University, Chicago, IL, ⁴Rheumatology, Northwestern University, Chicago, IL, ⁵FSM, Northwestern University, Chicago, IL
Background/Purpose: Systemic Lupus Erythematosus is a systemic autoimmune disease that has diverse manifestations that can occur over a long period of time. The complexity of…
Abstract Number: 1622 • 2017 ACR/ARHP Annual Meeting
Associations Among Classification Criteria Items within Systemic Lupus Erythematosus
Zahi Touma¹, Ricard Cervera², Ralph Brinks³, Chiara Tani⁴, Bimba F. Hoyer⁵, Karen H. Costenbader⁶, Valentina Lorenzoni⁷, Gian Sebastiani⁸, Sandra V. Navarra⁹, Eloisa Bonfa¹⁰, Rosalind Ramsey-Goldman¹¹, Sara K. Tedeschi¹², Thomas Doerner¹³, Sindhu Johnson¹⁴, Martin Aringer¹⁵ and Marta Mosca¹⁶, ¹Rheumatology, University of Toronto, Division of Rheumatology, Institute of Health Policy, Management and Evaluation, Toronto, ON, Canada, ²Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain, ³Hiller Center for Research in Rheumatology, Dusseldorf, Germany, ⁴University of Pisa, Pisa, Italy, ⁵Charité University Medicine, Department of Medicine/Rheumatology and Clinical Immunology and German Rheumatism Research Centre Berlin (DRFZ), Berlin, Germany, ⁶Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁷Sant Anna Scuola Universitaria Superiore Pisa, Pisa, Italy, ⁸Ospedale San Camillo, Rome, Italy, ⁹Rheumatology, University of Santo Tomas Hospital, Manila, Philippines, ¹⁰Rheumatology Divison, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ¹¹FSM, Northwestern University, Chicago, IL, ¹²Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ¹³Charité Universitätmedizin Berlin and DRFZ, Berlin, Germany, ¹⁴Division of Rheumatology, University of Toronto, Toronto Scleroderma Program, Sinai Health Systems and University Health Network, Toronto, ON, Canada, ¹⁵Medicine III, University Medical Center and Faculty of Medicine at the TU Dresden, Dresden, Germany, ¹⁶Rheumatology Unit, University of Pisa, Pisa, Italy
Background/Purpose: An EULAR/ACR –sponsored project is currently developing new weighted SLE classification criteria including laboratory/clinical items. Combinations of symptoms appear commonly in SLE arguing against…
Abstract Number: 730 • 2015 ACR/ARHP Annual Meeting
Early Symptoms of Systemic Lupus Erythematosus As Reported By Members of the German Lupus Erythematosus Patient Association
Nicolai Leuchten¹, Barbara Milke¹, Borgi Winker-Rohlfing², David I. Daikh³, Thomas Dorner⁴, Sindhu R. Johnson⁵, Martin Aringer¹ and on behalf of the SLE Classification Criteria Steering Committee, ¹Medicine III, University Medical Center and Faculty of Medicine at the TU Dresden, Dresden, Germany, ²Lupus Erythematodes Selbsthilfegemeinschaft e.V., Wuppertal, Germany, ³Rheumatology, UCSF/VA Medical Center, San Francisco, CA, ⁴Charité University Medicine Berlin, Berlin, Germany, ⁵Dept of Rheumatology, Toronto Western and Mt. Sinai Hospitals, University of Toronto, Toronto, ON, Canada
Background/Purpose: EULAR and ACR have jointly funded a project to develop systemic lupus erythematosus (SLE) classification criteria, aiming at earlier and more accurate classification of…
Abstract Number: 774 • 2015 ACR/ARHP Annual Meeting
Anti-Nuclear Antibodies Have High Sensitivity for Systemic Lupus Erythematosus: Results of a Systematic Literature Review and Meta-Regression of Diagnostic Data
Nicolai Leuchten¹, Ralph Brinks², Annika Hoyer³, Monika Schoels⁴, Martin Aringer¹, Sindhu R. Johnson⁵, David I. Daikh⁶, Thomas Dorner⁷, George Bertsias⁸ and on behalf of the SLE Classification Criteria Steering Committee, ¹Medicine III, University Medical Center and Faculty of Medicine at the TU Dresden, Dresden, Germany, ²Hiller Center for Research in Rheumatology, Duesseldorf, Germany, ³Institute for Biometry and Epidemiology, German Diabetes Center, Duesseldorf, Germany, ⁴2nd Department of Medicine, Hietzing Hospital, Vienna, Austria, ⁵Dept of Rheumatology, Toronto Western and Mt. Sinai Hospitals, University of Toronto, Toronto, ON, Canada, ⁶Rheumatology, UCSF/VA Medical Center, San Francisco, CA, ⁷Charité University Medicine Berlin, Berlin, Germany, ⁸Rheumatology, Clinical Immunology, and Allergy, University of Crete, Heraklion, Greece
Background/Purpose: EULAR and ACR have jointly funded a project to improve existing SLE classification criteria, aiming at earlier and more accurate classification of the disease.…
Abstract Number: 887 • 2014 ACR/ARHP Annual Meeting
Serological and Clinical Characteristics of a Large Collection of Incomplete Lupus Erythematosus Patients
Teresa Aberle¹, Virginia C. Roberts¹, Julie M. Robertson¹, Joel M. Guthridge¹, Kathy L. Sivils², Astrid Rasmussen², David R. Karp³ and Judith James⁴, ¹Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ³Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX, ⁴Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK
Background/Purpose: Incomplete lupus (ILE) is defined as a condition in which patients present with signs of systemic autoimmunity and clinical manifestations compatible with systemic lupus…
Abstract Number: 2524 • 2013 ACR/ARHP Annual Meeting
Application of The 2012 Systemic Lupus International Collaborating Clinics Classification Criteria On a Regional Swedish Systemic Lupus Erythematosus Register
Anna Ighe¹, Örjan Dahlström², Thomas Skogh¹ and Christopher Sjöwall¹, ¹Deparment of clinical and experimental medicine, Linköping University, Linköping, Sweden, ²Department of behavioural sciences and learning, Linneaus Centre HEAD, Swedish Institute for Disability Research, Linköping, Sweden
Background/Purpose: In addition to the 1982 American College of Rheumatology criteria (ACR-82) for scientific classification of systemic lupus erythematosus (SLE), many clinicians find the 'Fries…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].